Concepedia

Chris J. Vlahos

CJ

Statistics

Publications

58

Citations

9.5K

H-Index

36

Active since

1985

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Indiana University – Purdue University Indianapolis

Joslin Diabetes Center

Brigham and Women's Hospital

Chris J. Vlahos is an author at Eli Lilly (United States) specializing in life sciences, cell signaling, and signal transduction.

Publications per year

1985–2009

58

Publications

58

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

Chris J. Vlahos, William F. Matter, K. Y. Hui et al. · Journal of Biological Chemistry · 1994 · 3.3K citations · Full text

, , +16

Phosphatidylinositol 3-Kinase Activation Is Required for Insulin Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation

Bentley Cheatham, Chris J. Vlahos, Lynn Cheatham et al. · Molecular and Cellular Biology · 1994 · 1K citations · Full text

, , +17

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.

Bentley Cheatham, Chris J. Vlahos, L Cheatham et al. · Molecular and Cellular Biology · 1994 · 622 citations

, , +17

Increased Protein Kinase C Activity and Expression of Ca <sup>2+</sup> -Sensitive Isoforms in the Failing Human Heart

Nancy Bowling, Richard A. Walsh, Guojie Song et al. · Circulation · 1999 · 457 citations

, , +10

Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States

Eva Chou, Izumi Suzuma, Kerrie J. Way et al. · Circulation · 2002 · 338 citations · Full text

, , +15

1–5 of 58